Together, this set of results demonstrates that the impact of the CRC cell-secretome on fibroblasts activation (α-SMA expression) and on TGFβ1 and HGF secretion were mostly independent of oncogenic KRAS except for LS174T, in which the α-SMA expression demonstrated a KRAS dependency. This evidence concerns the gene KRAS and colorectal carcinoma.